Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39312556.
- Also identified by DOI 10.1371/journal.pone.0311128 and PMC identifier 11419337.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0168960.].